Cite

MLA Citation

    Peter Huber et al.. “A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy.” Amyloid, vol. 26, 2019, pp. 203–209. http://access.bl.uk/ark:/81055/vdc_100101545828.0x000035
  
Back to record